BACKGROUND Invasive fungal infections are a major cause of morbidity and mortality in preterm infants. The authors conducted the first prospective, randomised controlled trial of nystatin compared with fluconazole for the prevention of fungal colonisation and invasive fungal infection in very low birth weight (VLBW) neonates. METHODS During a 12-month period, all VLBW neonates were assigned r...

background: iranian (lahijan) black tea caffeine has been previously shown to have antifungal activity against candida albicans. the aim of this study was to investigate whether the combination of caffeine and fluconazole (flu) has an effective antifungal activity on a flu-resistant (mic >64mgl-1) c. albicans ptcc5027. materials and methods: caffeine from lahijan black tea was extracted and its...

background the ability of candida albicans to form biofilms and adhere to host tissues and biomaterial surfaces is an important factor in its pathogenesis. one of the main characteristics of biofilms is their resistance to broad-spectrum anti-microbial drugs. objectives in the present study the formation of biofilm by c. albicans from different sources was evaluated. in addition, the minimum bi...

Candida dubliniensis is a recently described species of Candida associated with oral candidiasis in human immunodeficiency virus (HIV)-infected individuals. Nineteen oral isolates of C. dubliniensis recovered from 10 HIV-positive and 4 HIV-negative individuals and one vaginal isolate from an additional HIV-negative subject were assessed for fluconazole susceptibility by broth microdilution (BMD...

abstract       background and objectives: more candida albicans strains are reported resistant to fluconazole in patients with aids, cancer and organ recipients. fluconazole resistance can be attributed to changes in pathways of sterol biosynthesis, mutation in or overexpression of erg11 and the expression of cdr1, cdr2, and mdr1. this study aimed to compare the expression of cdr1, cdr2, and md...

Candida parapsilosis is an increasing cause of bloodstream infections (BSIs) in neonatal intensive care units (NICUs). It has been a persistent problem in the NICU of Hospital for Children and Adolescents, Helsinki University Central Hospital, Helsinki, Finland, since 1987. Fluconazole prophylaxis has been used to control the problem. The number of new infections has, however, increased markedl...

ObjectivesEmergence of azole resistance may contribute to recurrences vulvovaginal candidiasis. Thus, new drugs are needed improve the therapeutic options. We studied in vitro activity ibrexafungerp and comparators against Candida albicans isolates from vaginal samples blood cultures. Furthermore, were genotyped study compartmentalization genotypes relationship between genotype antifungal susce...

Abstract The article compares the experimental Fourier transform-infrared, Ultraviolet-visible (UV-vis), and proton nuclear magnetic resonance ( 1 H NMR) spectra of voriconazole fluconazole with density functional theory (DFT) calculations using five different functionals. results were compared previously reported data related to its analogue – posaconazole. analysis calculated infrared (IR) us...

Voriconazole (UK-109,496) is a novel triazole derivative with potent broad-spectrum activity against various fungi, including some that are inherently resistant to fluconazole, such as Candida krusei. In this study we compared the effect of subinhibitory concentrations of voriconazole and fluconazole on sterol biosynthesis of fluconazole-resistant and -susceptible Candida albicans strains, as w...

The in vitro activity of Schering 56592, a new azole drug, was compared with those of fluconazole and itraconazole against 103 isolates of Candida comprising 10 different species. Schering 56592 was more active than itraconazole and fluconazole, and it was active against many fluconazole-resistant isolates.